Noveome Biotherapeutics, Inc.

Amendment

CIK: 0001478304·Biotechnology·DELAWARE·Filed: Apr 14, 2016

Total Offering

$2,500,000

Amount Sold

$2,158,479

Investors

39

First Sale

Dec 31, 2015

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Terence Golden	Related Person
William Golden	Related Person
John McArthur	Related Person
A. Clarke Atwell	Related Person
Donald Wagner	Related Person
Robert Langer	Related Person

Company

Noveome Biotherapeutics, Inc.

100 TECHNOLOGY DRIVE

PITTSBURGH, PA, 15219

4127702600

SEC Filing

0001478304-16-000005

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.